Autotrader parent acquires Indianapolis-based Dickinson Fleet Services
Dickinson has about 1,000 employees overall, including 200 in Indianapolis. It operates 18 nationwide service centers and a fleet of more than 700 mobile repair units.
IBJ Staff
Articles
COVID-19 toll in Indiana rises by 3,630 cases, 39 deaths
Statewide hospitalizations due to COVID-19 rose from to 2,714 on Saturday to 2,836 on Sunday.
Lilly Endowment awards $17.2M to local groups providing emergency aid
The biggest chunk—$10.5 million—has been dedicated to 15 community and multi-service centers that offer a range of services, such as health care, child care, counseling, job training and youth development, as well as programs for seniors.
IBJ Podcast: What we know about the COVID-19 vaccine in Indiana
IBJ reporter John Russell has been looking for answers to basic questions about the vaccine, including: When can I get a vaccine? So we invited him onto the podcast to tell us what he’s learned.
Indiana reports 3,002 new COVID-19 cases, 56 more deaths
The state said 6,914 new individuals were tested for COVID-19, the fifth time in the past week that testing in that category has dropped below 10,000.
Indiana reports 5,429 more COVID-19 cases, 39 new deaths
Statewide hospitalizations due to COVID-19 dropped from 2,786 on Friday to 2,655 on Saturday, the lowest number since Nov. 14.
December sets high marks for COVID-19 cases, deaths in Indiana
Statewide hospitalizations due to COVID-19 dropped from 2,842 on Thursday to 2,786 on Friday, the lowest number since Nov. 15. COVID-19 patients occupy 31.6% of the state’s intensive care beds.
COVID-19 cases surge back above 6,000 in Indiana
Indiana has reported 373 total new deaths in the last three daily reports, an average of 124 per day.
IBJ’s top-clicked stories of 2020 focused on pandemic, restaurants
Stories with some connection to the pandemic dominated the list, but the top story was actually about Cracker Barrel’s move to open a “ghost kitchen” pilot in Indianapolis.
State reports another 4,819 COVID-19 cases, 109 new deaths
Reported cases have been on the rise for three straight days after dropping significantly over the Christmas holiday weekend.
Indiana reports 164 more deaths due to COVID-19
Statewide hospitalizations due to COVID-19 increased for the third straight day, from 2,866 on Sunday to 2,951 on Monday.
Indiana reports 2,494 new COVID-19 cases, 43 more deaths
Statewide hospitalizations due to COVID-19 increased for the second straight day, from 2,811 on Saturday to 2,866 on Sunday.
Indiana reports 3,806 new COVID-19 cases, 30 more deaths
Statewide hospitalizations due to COVID-19 dropped to 2,808 on Christmas Day, down from 2,918 on Christmas Eve.
New COVID-19 cases again top 5,000; 40 more deaths reported
Statewide hospitalizations due to COVID-19 dropped to 2,918 on Thursday, the lowest number since Nov. 15.
2020 YEAR IN REVIEW: IU Health plans huge downtown expansion
The hospital system plans to expand its footprint by eight blocks and build a $1.6 billion hospital just south of its century-old Methodist Hospital.
2020 YEAR IN REVIEW: Pandemic whipsaws shopping mall giant
The Indianapolis-based company closed the year by negotiating a lower price for its purchase of Michigan-based mall rival Taubman Centers Inc.
2020 YEAR IN REVIEW: Elanco to build HQ at former GM stamping plant
The blockbuster announcement secures Elanco’s future in central Indiana and provide a long-sought reuse for at least part of the stamping plant site, which has been vacant for almost a decade.
2020 YEAR IN REVIEW: Airport absorbs plunge in passengers
Passenger traffic at Indianapolis International Airport is expected to end 2020 45% lower than a year earlier, but airport leaders say they are confident they can keep the organization’s finances stable.
2020 YEAR IN REVIEW: Total Wine cracks Indiana market
The liquor superstore chain opened its first Indiana store in November after it succeeded in overturning a permit denial issued by the Indiana Alcohol and Tobacco Commission.
2020 YEAR IN REVIEW: Eli Lilly wins emergency approval for COVID-19 treatment
The U.S. Food and Drug Administration cleared the experimental drug for people 12 and older with mild or moderate symptoms not requiring hospitalization.